Follow
Steven A. Stacker
Steven A. Stacker
Tumour Angiogenesis Program, Peter MacCallum Cancer Centre, University of Melbourne, Australia
Verified email at petermac.org
Title
Cited by
Cited by
Year
VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
SA Stacker, C Caesar, ME Baldwin, GE Thornton, RA Williams, R Prevo, ...
Nature medicine 7 (2), 186-191, 2001
18462001
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
MG Achen, M Jeltsch, E Kukk, T Mäkinen, A Vitali, AF Wilks, K Alitalo, ...
Proceedings of the National Academy of Sciences 95 (2), 548-553, 1998
17011998
ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18).
MS Diamond, DE Staunton, AR de Fougerolles, SA Stacker, ...
The Journal of cell biology 111 (6), 3129-3139, 1990
11601990
Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF‐C/D receptor VEGFR‐3
T Mäkinen, T Veikkola, S Mustjoki, T Karpanen, B Catimel, EC Nice, ...
The EMBO journal, 2001
11412001
Lymphangiogenesis and cancer metastasis
SA Stacker, MG Achen, L Jussila, ME Baldwin, K Alitalo
Nature Reviews Cancer 2 (8), 573-583, 2002
10522002
Signalling via vascular endothelial growth factor receptor‐3 is sufficient for lymphangiogenesis in transgenic mice
T Veikkola, L Jussila, T Makinen, T Karpanen, M Jeltsch, TV Petrova, ...
The EMBO journal, 2001
9272001
Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease
ML Hibbs, DM Tarlinton, J Armes, D Grail, G Hodgson, R Maglitto, ...
Cell 83 (2), 301-311, 1995
8851995
Lymphangiogenesis and lymphatic vessel remodelling in cancer
SA Stacker, SP Williams, T Karnezis, R Shayan, SB Fox, MG Achen
Nature Reviews Cancer 14 (3), 159-172, 2014
8282014
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1.
AR de Fougerolles, SA Stacker, R Schwarting, TA Springer
The Journal of experimental medicine 174 (1), 253-267, 1991
7101991
Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation
P Baluk, T Tammela, E Ator, N Lyubynska, MG Achen, DJ Hicklin, ...
The Journal of clinical investigation 115 (2), 247-257, 2005
7032005
Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.
ME Cooper, D Vranes, S Youssef, SA Stacker, AJ Cox, B Rizkalla, ...
Diabetes 48 (11), 2229-2239, 1999
6801999
Sox18 induces development of the lymphatic vasculature in mice
M Francois, A Caprini, B Hosking, F Orsenigo, D Wilhelm, C Browne, ...
Nature 456 (7222), 643-647, 2008
6052008
Inhibition of Growth of C6 Glioma Cells in Vivo by Expression of Antisense Vascular Endothelial Growth Factor Sequence
M Saleh, SA Stacker, AF Wilks
Cancer research 56 (2), 393-401, 1996
5801996
Consensus guidelines for the use and interpretation of angiogenesis assays
P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ...
Angiogenesis 21, 425-532, 2018
5752018
VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses
TT Rissanen, JE Markkanen, M Gruchala, T Heikura, A Puranen, ...
Circulation research 92 (10), 1098-1106, 2003
5442003
VEGF‐C and VEGF‐D expression in neuroendocrine cells and their receptor, VEGFR‐3, in fenestrated blood vessels in human tissues
TA Partanen, J Arola, A Saaristo, L Jussila, A Ora, M Miettinen, SA Stacker, ...
The FASEB Journal 14 (13), 2087-2096, 2000
5012000
Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers
SA Stacker, K Stenvers, C Caesar, A Vitali, T Domagala, E Nice, S Roufail, ...
Journal of Biological Chemistry 274 (45), 32127-32136, 1999
4551999
Focus on lymphangiogenesis in tumor metastasis
MG Achen, BK McColl, SA Stacker
Cancer cell 7 (2), 121-127, 2005
4392005
The role of tumor lymphangiogenesis in metastatic spread
SA Stacker, ME Baldwin, MG Achen
The FASEB Journal 16 (9), 922-934, 2002
4382002
Vascular endothelial growth factor D is dispensable for development of the lymphatic system
ME Baldwin, MM Halford, S Roufail, RA Williams, ML Hibbs, D Grail, ...
Molecular and cellular biology, 2005
4192005
The system can't perform the operation now. Try again later.
Articles 1–20